216 related articles for article (PubMed ID: 1621098)
21. Evolution of the aldose reductase-related gecko eye lens protein rhoB-crystallin: a sheep in wolf's clothing.
van Boekel MA; van Aalten DM; Caspers GJ; Röll B; de Jong WW
J Mol Evol; 2001 Mar; 52(3):239-48. PubMed ID: 11428461
[TBL] [Abstract][Full Text] [Related]
22. Aldose reductase catalysis and crystallography. Insights from recent advances in enzyme structure and function.
Petrash JM; Tarle I; Wilson DK; Quiocho FA
Diabetes; 1994 Aug; 43(8):955-9. PubMed ID: 8039602
[TBL] [Abstract][Full Text] [Related]
23. Structure of a glutathione conjugate bound to the active site of aldose reductase.
Singh R; White MA; Ramana KV; Petrash JM; Watowich SJ; Bhatnagar A; Srivastava SK
Proteins; 2006 Jul; 64(1):101-10. PubMed ID: 16639747
[TBL] [Abstract][Full Text] [Related]
24. Probing flexibility and "induced-fit" phenomena in aldose reductase by comparative crystal structure analysis and molecular dynamics simulations.
Sotriffer CA; Krämer O; Klebe G
Proteins; 2004 Jul; 56(1):52-66. PubMed ID: 15162486
[TBL] [Abstract][Full Text] [Related]
25. The alrestatin double-decker: binding of two inhibitor molecules to human aldose reductase reveals a new specificity determinant.
Harrison DH; Bohren KM; Petsko GA; Ringe D; Gabbay KH
Biochemistry; 1997 Dec; 36(51):16134-40. PubMed ID: 9405046
[TBL] [Abstract][Full Text] [Related]
26. Aldose reductase and its inhibition in the control of diabetic complications.
Narayanan S
Ann Clin Lab Sci; 1993; 23(2):148-58. PubMed ID: 8457142
[TBL] [Abstract][Full Text] [Related]
27. Human aldose reductase: rate constants for a mechanism including interconversion of ternary complexes by recombinant wild-type enzyme.
Grimshaw CE; Bohren KM; Lai CJ; Gabbay KH
Biochemistry; 1995 Nov; 34(44):14356-65. PubMed ID: 7578039
[TBL] [Abstract][Full Text] [Related]
28. Methylglyoxal metabolism and diabetic complications: roles of aldose reductase, glyoxalase-I, betaine aldehyde dehydrogenase and 2-oxoaldehyde dehydrogenase.
Vander Jagt DL; Hunsaker LA
Chem Biol Interact; 2003 Feb; 143-144():341-51. PubMed ID: 12604221
[TBL] [Abstract][Full Text] [Related]
29. Probing the active site of human aldose reductase. Site-directed mutagenesis of Asp-43, Tyr-48, Lys-77, and His-110.
Tarle I; Borhani DW; Wilson DK; Quiocho FA; Petrash JM
J Biol Chem; 1993 Dec; 268(34):25687-93. PubMed ID: 8245005
[TBL] [Abstract][Full Text] [Related]
30. Substrate specificity of human aldose reductase: identification of 4-hydroxynonenal as an endogenous substrate.
Vander Jagt DL; Kolb NS; Vander Jagt TJ; Chino J; Martinez FJ; Hunsaker LA; Royer RE
Biochim Biophys Acta; 1995 Jun; 1249(2):117-26. PubMed ID: 7599164
[TBL] [Abstract][Full Text] [Related]
31. Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications.
Yabe-Nishimura C
Pharmacol Rev; 1998 Mar; 50(1):21-33. PubMed ID: 9549756
[No Abstract] [Full Text] [Related]
32. Studies on pig aldose reductase. Identification of an essential arginine in the primary and tertiary structure of the enzyme.
Kubiseski TJ; Green NC; Borhani DW; Flynn TG
J Biol Chem; 1994 Jan; 269(3):2183-8. PubMed ID: 8294474
[TBL] [Abstract][Full Text] [Related]
33. The role of Cys-298 in aldose reductase function.
Balendiran GK; Sawaya MR; Schwarz FP; Ponniah G; Cuckovich R; Verma M; Cascio D
J Biol Chem; 2011 Feb; 286(8):6336-44. PubMed ID: 21084309
[TBL] [Abstract][Full Text] [Related]
34. Aldose and aldehyde reductases: structure-function studies on the coenzyme and inhibitor-binding sites.
El-Kabbani O; Old SE; Ginell SL; Carper DA
Mol Vis; 1999 Sep; 5():20. PubMed ID: 10493777
[TBL] [Abstract][Full Text] [Related]
35. Structural and kinetic determinants of aldehyde reduction by aldose reductase.
Srivastava S; Watowich SJ; Petrash JM; Srivastava SK; Bhatnagar A
Biochemistry; 1999 Jan; 38(1):42-54. PubMed ID: 9890881
[TBL] [Abstract][Full Text] [Related]
36. Catalytic effectiveness of human aldose reductase. Critical role of C-terminal domain.
Bohren KM; Grimshaw CE; Gabbay KH
J Biol Chem; 1992 Oct; 267(29):20965-70. PubMed ID: 1400412
[TBL] [Abstract][Full Text] [Related]
37. Structural features of the aldose reductase and aldehyde reductase inhibitor-binding sites.
El-Kabbani O; Wilson DK; Petrash M; Quiocho FA
Mol Vis; 1998 Sep; 4():19. PubMed ID: 9756955
[TBL] [Abstract][Full Text] [Related]
38. Sequence of pig lens aldose reductase and electrospray mass spectrometry of non-covalent and covalent complexes.
Jaquinod M; Potier N; Klarskov K; Reymann JM; Sorokine O; Kieffer S; Barth P; Andriantomanga V; Biellmann JF; Van Dorsselaer A
Eur J Biochem; 1993 Dec; 218(3):893-903. PubMed ID: 8281941
[TBL] [Abstract][Full Text] [Related]
39. Kinetic and spectroscopic evidence for active site inhibition of human aldose reductase.
Nakano T; Petrash JM
Biochemistry; 1996 Aug; 35(34):11196-202. PubMed ID: 8780524
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical localization for aldose reductase in diabetic lenses.
Akagi Y; Kador PF; Kinoshita JH
Invest Ophthalmol Vis Sci; 1987 Jan; 28(1):163-7. PubMed ID: 3100473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
